Pharmafile Logo
Pharmafocus logo
Advanced Search
medication

Statins revealed to potentially aid cancer treatment

January 25, 2017
Research and Development Cancer, University of Kansan, statins

New research, conducted at the University of Kansas, has emerged that reveal a potential use for statins beyond their current …

News
shutterstock_187433765

Two-step treatment cuts off cancer’s backup defences

January 25, 2017
Research and Development Cancer, sarcoma, washington university

New research conducted at Washington University’s School of Medicine and published in Cell Reports details a new method for fighting …

News
cancer_cells

Breakthrough treatment for pancreatic cancer doubles survival rates

January 25, 2017
Research and Development CRUK, Cancer Research UK, Pancreatic cancer

Research led by Liverpool University and funded by Cancer Research UK has shown that a combination treatment of two off-patent …

News

Indian pharma firm caught shredding documents at 1am by FDA

January 24, 2017
Manufacturing and Production, Research and Development FDA, Hetero Labs, observations

Hetero Labs, an Indian pharmaceutical firm, has been observed by the FDA shredding what the FDA judged to be controlled …

News
pharmafocus_march

Pharmafocus January/February is now live!

January 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, digital edition

Inside this issue…

News
abbvie_0

EMA Accelerated Assessment for AbbVie’s hepatitis C regimen

January 24, 2017
Manufacturing and Production, Research and Development AbbVie, EMA, hepatitis C

AbbVie has announced that its investigational, pan-genotypic regimen of Glecaprevir/Pibrentasvir has been awarded Accelerated Assessment by the European Medicines Agency …

News
phrma_logo

US Pharma launches multi-million dollar media campaign to deflect pricing criticism

January 24, 2017
Manufacturing and Production, Medical Communications PhMRA, Trump

In response to a number of recent criticisms over pricing including president Trump’s message that pharma companies are “getting away …

News
roche_close

Roche’s Actemra granted Priority Review by FDA

January 24, 2017
Manufacturing and Production, Sales and Marketing Actemra, FDA, Roche, priority review

Roche’s drug, Actemra (also known as RoActemra in Europe), has been granted priority review designation by the FDA for the …

News
computer_doctor

Thinking big data

January 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, IBM Watson Health, ibm

The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough …

Feature
kaleo

Rival to EpiPen to be made available to many for free

January 23, 2017
Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival

Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …

News
vaccination-1215279_960_720

CEPI backed by Bill Gates raises funds to combat epidemics

January 23, 2017
Medical Communications, Sales and Marketing Bill & Melinda Gates foundation, Bill Gates, CEPI

CEPI, the Coalition for Epidemic Preparedness Innovations, have launched the beginning of its fundraising initiative – with the aim of …

News
treasure_map

Leaflets offering gold coins for paediatricians appear at Bengaluru event

January 23, 2017
Medical Communications, Sales and Marketing India, PEDICON

Pharmaceutical firms in India are not allowed to offer any kind of reimbursement for privileging certain treatment over others, this …

News

Artificial skin development has implications for clinical trials

January 23, 2017
Medical Communications, Sales and Marketing Seoul National University Hospital, artificial skin, dermatology

Researchers from Seoul National University Hospital have announced that it has developed a microchip that has been designed to replicate …

News

BMS receives $625 million patent settlement boost from Merck

January 23, 2017
Sales and Marketing BMS, MSD, Merck, keytruda, opdivo

Bristol-Myers Squibb were in desperate need of releasing good news after the brief announcement that it would no longer be …

News
mallinckrodt-project

Company in 85,000% infant epilepsy drug price increase receives $100 million fine

January 23, 2017
Sales and Marketing Mallinckrodt, Martin Skhreli

Mallinckrodt Pharmaceuticals has hit the headlines for particularly dispiriting reasons – with further evidence of practise by some companies that …

News
shutterstock_141105490

Asia-Pacific flu market to hit $1.71bn by 2022

January 20, 2017
Business Services, Medical Communications APAC, GBI Research

According to new data from intelligence provider GBI Research, the flu vaccines market in the Asia-Pacific (APAC) region is set …

News
biopsy

“Biggest leap in decades” for prostate cancer, 1 in 4 could avoid biopsies

January 20, 2017
Medical Communications, Research and Development Biposy, prostate cancer

A new study has estimated that one in four men could avoid unnecessary invasive biopsies to detect prostate cancer – …

News

J&J’s Imbruvica scores fifth FDA lymphoma approval

January 20, 2017
Medical Communications, Research and Development, Sales and Marketing FDA, Marginal Zone Lymphoma, imbruvica

Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 20, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …

News
jenny_tragner_-_main

Pharmaceutical R&D tax credit regulatory legislation: The need for clarity

January 20, 2017
Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile

Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026